BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26872557)

  • 1. Season of diagnosis is associated with overall survival in patients with diffuse large B-cell lymphoma but not with Hodgkin's lymphoma - A population-based Swedish Lymphoma Register study.
    Székely E; Lindén O; Peterson S; Jerkeman M
    Eur J Haematol; 2016 Oct; 97(4):393-8. PubMed ID: 26872557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma - a Swedish population-based study.
    Hedström G; Peterson S; Berglund M; Jerkeman M; Enblad G;
    Acta Oncol; 2015 Jun; 54(6):924-32. PubMed ID: 25843161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in survival of diffuse large B-cell lymphoma in relation to age, gender, International Prognostic Index and extranodal presentation: a population based Swedish Lymphoma Registry study.
    Székely E; Hagberg O; Arnljots K; Jerkeman M
    Leuk Lymphoma; 2014 Aug; 55(8):1838-43. PubMed ID: 24138330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
    Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
    Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study.
    Wästerlid T; Mohammadi M; Smedby KE; Glimelius I; Jerkeman M; Bottai M; Eloranta S
    J Intern Med; 2019 Apr; 285(4):455-468. PubMed ID: 30368947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study.
    Munch-Petersen HD; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Sniegowski MC; Vemuganti GK; Heegaard S
    JAMA Ophthalmol; 2015 Feb; 133(2):165-73. PubMed ID: 25393033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of age on survival of diffuse large B-cell lymphoma - a population-based study.
    Hedström G; Hagberg O; Jerkeman M; Enblad G;
    Acta Oncol; 2015 Jun; 54(6):916-23. PubMed ID: 25519707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
    Castillo JJ; Winer ES; Olszewski AJ
    Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.
    Evens AM; Kanakry JA; Sehn LH; Kritharis A; Feldman T; Kroll A; Gascoyne RD; Abramson JS; Petrich AM; Hernandez-Ilizaliturri FJ; Al-Mansour Z; Adeimy C; Hemminger J; Bartlett NL; Mato A; Caimi PF; Advani RH; Klein AK; Nabhan C; Smith SM; Fabregas JC; Lossos IS; Press OW; Fenske TS; Friedberg JW; Vose JM; Blum KA
    Am J Hematol; 2015 Sep; 90(9):778-83. PubMed ID: 26044261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
    Gundrum JD; Mathiason MA; Moore DB; Go RS
    J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of fine-needle aspiration cytology in diagnosis of Hodgkin's lymphoma and anaplastic large cell lymphoma: one centre experience.
    Kolonić SO; Prasek-Kudrna K; Roso V; Radić-Kristo D; Planinc-Peraica A; Dzebro S; Kardum-Skelin I; Jaksić B
    Coll Antropol; 2010 Mar; 34(1):75-9. PubMed ID: 20432736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma.
    Li WX; Dai SX; An SQ; Sun T; Liu J; Wang J; Liu LG; Xun Y; Yang H; Fan LX; Zhang XL; Liao WQ; You H; Tamagnone L; Liu F; Huang JF; Liu D
    Aging (Albany NY); 2021 Apr; 13(8):11833-11859. PubMed ID: 33885377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unstaged Diffuse Large B-Cell Lymphoma in the United States: Predictors and Patient Outcomes.
    Bista A; Sharma S; Rijwani T; Shah BK
    Anticancer Res; 2017 Apr; 37(4):1935-1939. PubMed ID: 28373463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma.
    Baecklund E; Sundström C; Ekbom A; Catrina AI; Biberfeld P; Feltelius N; Klareskog L
    Arthritis Rheum; 2003 Jun; 48(6):1543-50. PubMed ID: 12794821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insurance status is related to diffuse large B-cell lymphoma survival.
    Han X; Jemal A; Flowers CR; Sineshaw H; Nastoupil LJ; Ward E
    Cancer; 2014 Apr; 120(8):1220-7. PubMed ID: 24474436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Disease Location and Treatment With Survival in Diffuse Large B-Cell Lymphoma of the Eye and Ocular Adnexal Region.
    Ahmed AH; Foster CS; Shields CL
    JAMA Ophthalmol; 2017 Oct; 135(10):1062-1068. PubMed ID: 28880986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjects.
    Smyth L; Blunt DN; Gatov E; Nagamuthu C; Croxford R; Mozessohn L; Cheung MC
    Br J Haematol; 2020 Nov; 191(3):396-404. PubMed ID: 32304100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
    Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
    Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and treatment-related features determining the risk of late relapse in patients with diffuse large B-cell lymphoma.
    Modvig L; Vase M; d'Amore F
    Br J Haematol; 2017 Oct; 179(1):75-82. PubMed ID: 28653321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients.
    Yoon JH; Kim JW; Jeon YW; Lee SE; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Park CW; Cho SG
    Korean J Intern Med; 2015 May; 30(3):362-71. PubMed ID: 25995667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.